Vara Receives World-First CE Certification for Autonomous AI in Breast Cancer Screening

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Technology
Biotechnology
Health
Biometrics
Consumer
Apps/Applications
Radiology
Artificial Intelligence
Oncology
Medical Devices
Software
Health Technology
Hardware
Women
Vara

More Like This

Vara earns CE mark as the only AI authorized for an independent second read in mammography, and expands in Europe

Vara receives CE mark for tomosynthesis AI - extending Europe’s leading screening-grade AI portfolio to 3D

PR Newswire associated0

ScreenPoint Medical Showcases Global Momentum for Transpara(R) Breast AI at EUSOBI

PR Newswire associated0

ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR

PR Newswire associated0

ScreenPoint Medical: AI-Enhanced Mammography Screening Significantly Improves Breast Cancer Detection and Reduces Radiologist Workload

PR Newswire associated0

Volpara Health Surpasses 300 Peer-Reviewed Papers

PR Newswire associated0

Transpara Announces New FDA Clearance Designed to Improve Breast Cancer Detection at RSNA

PR Newswire associated0

ScreenPoint Medical Hits New Milestones